Latest News

Date Title Topic
08 Jun 2016 Immune Modulation in Colorectal and Anal Cancers Gastrointestinal cancers - Cancer Immunology and Immunotherapy
07 Jun 2016 EMA Recommends Extension of Therapeutic Indications for Brentuximab Vedotin Haematologic malignancies - Anticancer agents & Biologic therapy
07 Jun 2016 ESMO Workshop: Cancer Patient Advocacy Networks Driving Research
06 Jun 2016 FDA Approves New Diagnostic Imaging Agent to Detect Rare Neuroendocrine Tumours Imaging - Endocrine and neuroendocrine tumours
03 Jun 2016 FDA Approves First Blood Test to Detect EGFR mutations associated with NSCLC Personalised medicine - Lung and other thoracic tumours
03 Jun 2016 ESMO is Hiring!
02 Jun 2016 Everolimus for the Treatment of Advanced, Non-Functional Neuroendocrine Tumours of the Lung or Gastrointestinal Tract (RADIANT-4): a Randomised, Placebo-Controlled, Phase 3 Study Endocrine and neuroendocrine tumours
02 Jun 2016 FDA Approves New Diagnostic Imaging Agent to Detect Recurrent Prostate Cancer Genitourinary cancers - Imaging
01 Jun 2016 All European Scientific Articles to be Freely Accessible by 2020 Bioethics, legal and economic issues
31 May 2016 EMA Recommends to Refuse Marketing Authorisation for Ixazomib Haematologic malignancies - Anticancer agents & Biologic therapy
30 May 2016 Withdrawal of the EU Marketing Authorisation Application for Rociletinib Lung and other thoracic tumours - Anticancer agents & Biologic therapy
24 May 2016 Responsible and Effective Sharing of Cancer Genome Data Personalised medicine
23 May 2016 Unprecedented Progress in the Treatment of NSCLC Lung and other thoracic tumours - Cancer Immunology and Immunotherapy - Anticancer agents & Biologic therapy
20 May 2016 FDA Grants Accelerated Approval to Nivolumab for the Treatment of Hodgkin Lymphoma Haematologic malignancies - Cancer Immunology and Immunotherapy